Biologics not causing elevated skin cancer risk in RA: ARAD


The risk of melanoma appears to be higher in RA patients compared to the general population regardless of whether they’ve been treated with anti-TNFs, data from ARAD shows. Presenting the findings at a session on biologics registries Professor Lyn March said it was probably the rheumatoid arthritis status itself, and possibly methotrexate exposure, that increased skin ...


Already a member? Login to keep reading


OR
© 2017 the limbic